FDA eases U.S. chemotherapy shortage by allowing imports from China.

The FDA has allowed imports of chemotherapy drugs made in China to ease the shortage in the US. The move comes after the FDA found that the drugs met US safety standards. The shortage of chemotherapy drugs has been a problem in the US for years, with some patients having to delay or skip treatment due to the lack of supply.